Mar. 30, 2015 - TISCH MSRCNY Faces Funding Crisis for Experimental Research Facility

We are currently the only center in the United States that is conducting an FDA approved clinical trial

using stem cells in patients with MS. The goal of the Phase I trial is to determine whether or not the

therapy is safe and effective. We hope that this will lead to additional future trials and that with our

concurrent research, the reversal of disability will become a realistic therapeutic objective.

Achieving our goals requires us to overcome two immediate hurdles. The first is the closure of the animal research facility which we are currently using, scheduled to occur on May 31^st, 2015. This

facility is located less than a block away at Roosevelt Hospital, and its closure is a result of Mt. Sinai’s

recent acquisition of St. Luke’s Roosevelt Hospital Center. Unfortunately, it could not come at a worse

time for us as animal research is a critical component of all of the work at the Center, and especially of

our stem cell program. The second critical issue is the need to expand our regenerative disease

program, in particular, our stem cell facility. 

Having previously anticipated our needs, we have 10,000 square feet of undeveloped space on the

third floor of the Tisch MS Center slated to be an expanded research facility. This new site will be

designated as the Institute  for Experimental and Stem Cell Research at the Tisch MS Research Center   

of New York. The cost of the project is roughly $10 million, and construction is expected to take 16

weeks and will commence as soon as funding is secured. 

In order to continue our trend of surpassing our academic goals, Tisch MSRCNY urgently needs to

begin the rapid development of the area on the third floor in order to ensure that our studies carry on

without devastating interruptions or delays. We are asking all of our friends, family, advocates, donors,

and supporters to please consider making a gift so we can move ahead with our research plans.

Thank you for your consideration. 

Click here to support Tisch MS Research Center